BioRestorative Therapies Inc. (BRTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioRestorative Therapies ...

    NASDAQ: BRTX · Real-Time Price · USD
    1.51
    0.01 (0.67%)
    At close: Oct 06, 2025, 9:51 AM

    BioRestorative Therapies Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 547.89K 884.38K 1.71M 21.03M
    Short-Term Investments
    		 10.18M 10.18M 13.04M n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 148.7K n/a n/a n/a
    Receivables
    		 188.4K 19.3K 16K 5K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 223.23K n/a n/a n/a
    Total Current Assets
    		 11.14M 11.39M 15.13M 21.47M
    Property-Plant & Equipment
    		 362.94K 507.5K 502.76K 395.8K
    Goodwill & Intangibles
    		 623.95K 713.69K 803.44K 589.74K
    Total Long-Term Assets
    		 1.14M 1.22M 1.31M 985.54K
    Total Assets
    		 12.28M 12.61M 16.43M 22.45M
    Account Payables
    		 483.07K 189.39K 170.9K 50.83K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 162.32K 139.33K 58.97K
    Other Current Liabilities
    		 2.52M 1.46M 5.4M 106.6K
    Total Current Liabilities
    		 3.75M 2.61M 5.98M 363.82K
    Long-Term Debt
    		 n/a n/a n/a 191.03K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a 162.32K 492.68K
    Total Liabilities
    		 3.75M 2.61M 6.14M 856.5K
    Total Debt
    		 n/a 162.32K 301.64K 670.7K
    Book Value
    		 8.53M 10M 10.29M 21.6M
    Book Value Per Share
    		 1.10 2.37 2.84 18.18
    Common Stock
    		 692.00 471.00 369.00 353.00
    Retained Earnings
    		 -155.68M -146.7M -136.28M -134.15M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 8.53M 10M 10.29M 21.6M
    Total Investments
    		 10.18M 10.18M 13.04M n/a

    Add to Watchlist